The Infectious Diseases Society of America proposed a new approval option for companies interested in developing drugs to treat patients with serious infections where few or no treatment options exist.
Read the full report in Becker's Hospital Review on IDSA's proposal to the House Energy and Commerce Committee Subcommittee on Health.
Read the full report in Becker's Hospital Review on IDSA's proposal to the House Energy and Commerce Committee Subcommittee on Health.
